Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

The article's findings are uncertain and should be viewed with caution.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Two women lost hair after mesotherapy for hair loss, with one having permanent and the other temporary hair loss.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Finasteride reduces some inflammation in BPH but not all.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

A new finasteride treatment may quickly and effectively promote hair regrowth.

PRP injections are safe but don't significantly improve Peyronie's Disease.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.